UnknownNot Applicable

Study of Biomarkers in Diabetic Chronic Wounds

China930 participantsStarted 2023-07-01

Plain-language summary

This study aims to discover, verify and evaluate the potential biomarkers with regard to the diagnosis, prognostic and/or prediction of diabetic chronic wounds.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age between 18 and 75;
✓. Signed the informed consent form；
✓. Subjects in the ND group are the healthy participants without diabetes；
✓. Subjects in the NWD group are the diabetic participants without newly identified wounds；
✓. Subjects in the CWD group are the diabetic participants with chronic wounds

Exclusion criteria

✕. With sever acute underlying diseases of the brain, heart, lungs, liver and/or kidney;
✕. No diabetes but combined with lower limb arterial stenosis, occlusion or other conditions affecting wound healing or other causes of wounds such as varicose veins in the lower limbs;
✕. Special exclusion criteria for blood, urine and stool samples taking.

What they're measuring

Bioindicators with differences among groups

Timeframe: Through study completion, an average of 1 year

Basic clinical and demographic information of participants in groups

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT05342740

SponsorYibing Wang

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12

Contact for this trial

Wang Yibing, Doctor

+86-0531-89268253 wyb0616@163.com

View on ClinicalTrials.gov More Diabetes Mellitus trials